Search research articles
Contact Us
Filters
Showing results (1-10 of 131) with videos related to
Page
of 14
Sort By:
The American Journal of Psychiatry
|
April 2, 2015
Evidence for schizophrenia as a disorder of neuroplasticity
Robert E McCullumsmith
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 9, 2014
Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction
Robert E McCullumsmith, Gerard Sanacora
Schizophrenia Research
|
September 10, 2022
Postmortem, in silico, and clinical studies focused on perturbations of glutamate neurobiology in schizophrenia
Robert E McCullumsmith, Laura M Rowland
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 9, 2023
Moving beyond descriptive nosology: an argument for negative valence systems disorder
Elizabeth K Lucas, Robert E McCullumsmith
Schizophrenia Bulletin
|
March 21, 2026
Introduction to Bioenergetics Theme Issue
Laura M Rowland, Robert E McCullumsmith
Annals of the New York Academy of Sciences
|
December 20, 2003
Expression of transcripts for the vesicular glutamate transporters in the human medial temporal lobe
Robert E McCullumsmith, James H Meador-Woodruff
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 19, 2002
Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder
Robert E McCullumsmith, James H Meador-Woodruff
Biological Psychiatry
|
November 25, 2010
Novel approaches to the study of postmortem brain in psychiatric illness: old limitations and new challenges
Robert E McCullumsmith, James H Meador-Woodruff
Translational Psychiatry
|
November 17, 2021
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Ali S Imami, Robert E McCullumsmith, Sinead M O'Donovan
Bipolar Disorders
|
October 21, 2009
Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia
Akihito Uezato, James H Meador-Woodruff, Robert E McCullumsmith
Page
of 14
Search research articles
Search
Showing results (1-10 of 131) with videos related to
Sort By:
Page
of 14
The American Journal of Psychiatry
|
April 2, 2015
Evidence for schizophrenia as a disorder of neuroplasticity
Robert E McCullumsmith
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 9, 2014
Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction
Robert E McCullumsmith, Gerard Sanacora
Schizophrenia Research
|
September 10, 2022
Postmortem, in silico, and clinical studies focused on perturbations of glutamate neurobiology in schizophrenia
Robert E McCullumsmith, Laura M Rowland
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 9, 2023
Moving beyond descriptive nosology: an argument for negative valence systems disorder
Elizabeth K Lucas, Robert E McCullumsmith
Schizophrenia Bulletin
|
March 21, 2026
Introduction to Bioenergetics Theme Issue
Laura M Rowland, Robert E McCullumsmith
Annals of the New York Academy of Sciences
|
December 20, 2003
Expression of transcripts for the vesicular glutamate transporters in the human medial temporal lobe
Robert E McCullumsmith, James H Meador-Woodruff
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 19, 2002
Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder
Robert E McCullumsmith, James H Meador-Woodruff
Biological Psychiatry
|
November 25, 2010
Novel approaches to the study of postmortem brain in psychiatric illness: old limitations and new challenges
Robert E McCullumsmith, James H Meador-Woodruff
Translational Psychiatry
|
November 17, 2021
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Ali S Imami, Robert E McCullumsmith, Sinead M O'Donovan
Bipolar Disorders
|
October 21, 2009
Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia
Akihito Uezato, James H Meador-Woodruff, Robert E McCullumsmith
Page
of 14